The Best of Canadian Science and Technology
With sales forecasted to double over the next two years, WELL Health Technologies (WELL Health Technologies Stock Quote, Chart, News TSX:WELL) … [Read more...] about WELL Health Technologies gets bullish new $9.00 target from Stifel
Beacon Securities analyst Doug Cooper made the case for Protech Home Medical (Protech Home Medical Stock Quote, Chart, News TSXV:PTQ) in an update to … [Read more...] about Beacon Securities says it is still bullish on Protech Home Medical
After a rough second quarter, look for Blackline Safety (Blackline Safety Stock Quote, Chart, News TSXV:BLN) to rebound on strong organic growth, says … [Read more...] about Blackline Safety gets price target raise from PI Financial
Analyst Greg MacDonald of LodeRock Research likes the growth potential of fintech name VersaBank (VersaBank Stock Quote, Chart, News TSX:VB), which … [Read more...] about VersaBank has lots of upside, says LodeRock Research
AcuityAds (AcuityAds Stock Quote, Chart, News TSX:AT) has been on fire lately but there’s likely more where that came from, says Echelon Wealth … [Read more...] about AcuityAds gets huge price target raise at Echelon
Expect a Phase 3 trial for Appili Therapeutics’s (Appili Therapeutics Stock Quote, Chart, News TSXV:APLI) COVID-19 drug favipiravir, says Mackie … [Read more...] about Appili Therapeutics is an interesting COVID-19 play, Mackie says
Drone Delivery Canada (Drone Delivery Canada Stock Quote, Chart, News TSXV:FLT) brought home some mixed results in its latest quarter, according to … [Read more...] about Drone Delivery Canada stock may take a little longer to deliver: Echelon
Descartes Systems Group (Descartes Systems Group Stock Quote, Chart, News TSX:DSG)) just received a “Buy” rating and $67.00 per share target price … [Read more...] about Descartes Systems still has 20 per cent upside, RBC says
The immediate road ahead may be a little more bumpy for the tech sector but the long term prospects for names like Kinaxis (Kinaxis Stock Quote, … [Read more...] about The tech sector pullback reveals opportunities, National Bank says
Mackie Research analyst André Uddin reviewed the state of affairs for drug developer Bellus Health (Bellus Health Stock Quote, Chart, News TSX:BLU) in … [Read more...] about Bellus Health keeps “Hold” rating at Mackie Research Capital
